Ingenol-3-angelate CAS: 75567-37-2

CAS NO: 75567-37-2
Ingenol-3-angelate
Chemical Name: Ingenol mebutate
Molecular Formula: C25H34O6
Formula Weight: 430.53
CAS No.: 75567-37-2
Description Review
Description

Ingenol-3-angelate is a natural compound derived from the sap of the Euphorbia peplus plant. It has gained significant attention in recent years due to its potential therapeutic effects on different cancers, including skin cancer. Ingenol-3-angelate is also known as PEP005 and is currently being studied in clinical trials for its anti-cancer properties.

Chemical Name:

The chemical name for Ingenol-3-angelate is (1aR,1bS,4aS,7aR,7bS,8R,9R,9aS)-1b-acetoxy-9-hydroxy-9a-methyl-7-(1-oxobutyl)-octahydro-1a,5,8-trimethylspiro(naphthalene-2,4'-piperidine)-4,7-dione.

Molecular Formula:

The molecular formula for Ingenol-3-angelate is C25H34O6.

Formula Weight:

The formula weight for Ingenol-3-angelate is 430.53 g/mol.

CAS No:

The CAS number for Ingenol-3-angelate is 75567-37-2.

Top Ten Keywords from Google and Synonyms:

  1. Ingenol-3-Angelate
  2. PEP005
  3. Euphorbia peplus
  4. Skin cancer
  5. Anti-cancer agent
  6. Tumor necrosis factor
  7. Apoptosis
  8. Pro-inflammatory cytokines
  9. Protein kinase C
  10. Phorbol ester

Synonyms:

  1. 1b-Acetoxy-9-hydroxy-9a-methyl-7-(1-oxobutyl)decahydro-1a,5,8-trimethylspiro[2,4'-naphthalene-2',4-piperidine]-4,7-dione
  2. Ingenol-3-angelate
  3. PEP005
  4. EBC-46
  5. EA001
  6. LOPAC-I-1170

Health Benefits of this Product:

Ingenol-3-angelate has shown promising health benefits in various preclinical and clinical studies. Some of the potential health benefits are discussed below.

Anti-Cancer Effects: Ingenol-3-angelate has potent anti-cancer effects that have been demonstrated in various types of cancers, including basal cell carcinoma, squamous cell carcinoma, melanoma, and leukemia. It induces tumor cell death by activating protein kinase C (PKC), which leads to the production of reactive oxygen species, activation of caspases, and inhibition of pro-survival signaling pathways. It also stimulates the immune system by promoting the release of pro-inflammatory cytokines like tumor necrosis factor-alpha (TNF-α).

Wound Healing: Ingenol-3-angelate has been shown to promote wound healing by stimulating the proliferation and migration of keratinocytes, fibroblasts, and endothelial cells. It also enhances angiogenesis by increasing the expression of vascular endothelial growth factor (VEGF).

Anti-Inflammatory Effects: Ingenol-3-angelate has anti-inflammatory effects that can reduce inflammation in various inflammatory diseases like psoriasis and ulcerative colitis. It inhibits the production of pro-inflammatory cytokines like interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α).

Potential Effects:

Apart from the above-discussed health benefits, Ingenol-3-angelate has several other potential effects that are being studied.

Antiviral Effects: Ingenol-3-angelate may have antiviral effects against human immunodeficiency virus (HIV), herpes simplex virus (HSV), and influenza virus. It inhibits viral replication by blocking the transcription and translation of viral genes.

Analgesic Effects: Ingenol-3-angelate may have analgesic effects by reducing pain sensation through the modulation of ion channels and neurotransmitters.

Product Mechanism:

Ingenol-3-angelate exerts its biological effects by binding to and activating PKC, which is a key enzyme involved in cell signaling and regulation. The activation of PKC leads to the phosphorylation of downstream signaling molecules, which regulate various cellular processes, including cell growth, differentiation, and apoptosis. Ingenol-3-angelate activates two isoforms of PKC, PKCα, and PKCδ, which play a crucial role in its anti-cancer and anti-inflammatory effects.

Safety:

Ingenol-3-angelate is generally safe to use when applied topically to the skin under medical supervision. However, it may cause local skin reactions like erythema, edema, and blistering at the site of application. It should not be applied to open wounds or mucous membranes.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code